Oakridge International Posts Solid Quarter as Healthcare Tech Pipeline and RTLS Rollout Advance

Oakridge Internatinal Ltd ( (AU:OAK) ) has shared an update.

Oakridge International reported a solid December 2025 quarter, driven by growing healthcare technology revenues, stronger customer orders and disciplined cost control, with A$619,000 in customer receipts for the period and A$1.204 million for the half year supporting increased investment in inventory to meet anticipated demand. The company advanced key product and technology initiatives, including completion of RTLS enablement for its core platform ahead of initial production shipments in early 2026, progress on NuCaMS Enterprise infrastructure and Single Sign On integration, and continued alignment with evolving nurse call standards, while maintaining a robust project pipeline across Australian and selected international markets through strong partner activity, multisite rollouts and expanded assisted living programs that are expected to underpin higher revenues over the remainder of FY2026.

The most recent analyst rating on (AU:OAK) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on Oakridge Internatinal Ltd stock, see the AU:OAK Stock Forecast page.

More about Oakridge Internatinal Ltd

Oakridge International Limited is an Australian Internet of Things (IoT) and healthcare technology company that develops and distributes its own nurse call and assistive technology hardware and software solutions. The company targets multiple healthcare sectors, including hospitals, aged care, disability care and supported independent living, with a focus on wireless, real-time location systems (RTLS) and integrated platforms such as its NuCaMS solution suite.

Average Trading Volume: 10,738

Technical Sentiment Signal: Hold

Current Market Cap: A$2.67M

For a thorough assessment of OAK stock, go to TipRanks’ Stock Analysis page.